$4,576.86 travel Payment -- AstraZeneca to Dr. Daniel White

Payment Details

AI-Powered Analysis of This Payment

The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.

AstraZeneca made a $4.6K travel payment to Daniel White, a Endocrinology specialist in Erie, PA. The payment was associated with Biktarvy. The payment of $4,576.86 to Dr. Daniel White from AstraZeneca for travel and lodging related to Biktarvy is a significant amount for a single payment. This payment occurred on August 29, 2025, suggesting it was for a recent or upcoming event. The payment was made by AstraZeneca, a major pharmaceutical company, for a drug (Biktarvy) used in Endocrinology.

Patient Guidance: What This Payment Means for You

This payment was for travel and lodging expenses related to a pharmaceutical product, not for direct medical services to patients. Always discuss your treatment options with your healthcare provider and ask about alternatives.

Payment Context: Is This Amount Normal?

Payments for travel and lodging can vary widely in the Endocrinology specialty depending on the nature of the educational event or research activity.

Regulatory Context: Sunshine Act Requirements

This payment falls under the Sunshine Act provisions of the Affordable Care Act, requiring disclosure of financial relationships between drug manufacturers and healthcare providers.

Related Topics

This payment is related to the following healthcare transparency topics:

• pharmaceutical-payments
• travel-and-lodging
• endocrinology
• astrazeneca
• biktarvy
• physician-payments

Understanding travel Payments

Travel and lodging payments cover transportation and accommodation expenses for physicians attending conferences, advisory board meetings, or speaking engagements sponsored by pharmaceutical companies. These payments can be substantial, particularly for international travel or multi-day events.

Frequently Asked Questions About This Payment

What was this $4.6K payment for?

This was a travel payment of $4.6K from AstraZeneca to Daniel White, categorized as "Travel and Lodging". It was associated with Biktarvy. The payment was reported under the Sunshine Act (CMS Open Payments).

Does Daniel White accept pharmaceutical money?

Yes, Daniel White received this $4.6K payment from AstraZeneca. Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view Daniel White's full payment history on the CMS Open Payments database or on this site.

Is it legal for doctors to accept pharma payments?

Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.

Should I be concerned about this travel payment?

A travel payment of $4.6K should be evaluated in context. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.

How do I talk to my doctor about pharma relationships?

You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.

What types of pharma payments are most concerning?

Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.

Does pharma money affect what my doctor prescribes?

Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.

How does this compare to other doctors in Endocrinology?

To compare this payment against Endocrinology averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Endocrinology physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.

What does this payment reveal about Daniel White's relationship with AstraZeneca?

The payment covers 'Travel and Lodging', indicating expenses associated with attending an event or meeting. This $4.6K travel payment is part of the transparency data reported under the Sunshine Act.

Is this payment amount typical for Endocrinology?

Dr. Daniel White, an Endocrinologist, received this payment, linking it to the specialty's engagement with pharmaceutical companies.

What should patients do after learning about this payment?

This payment was for travel and lodging expenses related to a pharmaceutical product, not for direct medical services to patients.

What else should I know about this travel payment?

The specific drug mentioned is Biktarvy, which is relevant to the endocrinology field.

Related Reports

• View Dr. Daniel White's full payment report
• AstraZeneca full spending report
• Browse all Endocrinology payments
• Browse all payments in Pennsylvania
• Search for other payments